Characterization of receptors with a new negative image: Use in molecular docking and lead optimization

Proteins: Structure, Function and Genetics

Volumn 30, Issue 3, 1998, Pages 321-336

  Oshiro, C M ^a   Kuntz, I D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DOCK; Structure based molecular design; Surface characterization

Indexed keywords

ARTICLE; ENZYME ACTIVE SITE; GEOMETRY; IMAGE ANALYSIS; LIGAND BINDING; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN STRUCTURE; RECEPTOR BINDING; STRUCTURE ANALYSIS;

ALGORITHMS; BINDING SITES; ENZYME INHIBITORS; ENZYMES; HIV PROTEASE; LIGANDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE;

EID: 0032519997     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0134(19980215)30:3<321::AID-PROT11>3.0.CO;2-H     Document Type: Article

References (79)

1. Kuntz, I.D. Structure-based strategies for drug design and discovery. Science 257:1078-1082, 1992.
2. Kuntz, I.D., Meng, B.C., Shoichet, B.K. Structure-based molecular design. Accounts of Chem. Res. 27:117-123, 1994.
3. Kollman, P.A. Advances and continuing challenges in achieving realistic and predictive simulations of the properties of organic and biological molecules. Accounts of Chem. Res. 29:461-469, 1996.
4. Zhang, X.J., Matthews, B.W. Conservation of solvent-binding sites in 10 crystal forms of T4 lysozyme. Prot. Sci. 3:1031-1039, 1994.
5. Allen, K.N., Bellamacina, C.R., Ding, X. C., et al., An experimental approach to mapping the binding surfaces of crystalline proteins. J. Phys. Chem. 100:2605-2611, 1996.
6. Shuker, S.B., Hajduk, P.J., Meadows, R.P., Fesik, S.W. Discovering high-affinity ligands for proteins-Sar By Nmr. Science 274:1531-1534, 1996.
7. Connolly, M.L. Solvent-accessible surfaces of proteins and nucleic acids. Science 221:709-713, 1983.
8. Fischer, D., Lin, S.L., Wolfson, H.L., Nussinov, R. A geometry-based suite of molecular docking processes. J. Molec. Biol. 248:459-477, 1995.
9. Norel, R., Fischer, D., Wolfson, H.J., Nussinov, R. Molecular surface recognition by a computer vision-based technique. Prot. Eng. 7:39-46, 1994.
10. Norel, R., Lin, S.L., Wolfson, H.J., Nussinov, R. Molecular surface complementarity at protein-protein interfaces: The critical role played by surface normals at well placed, sparse, points in docking. J. Mol. Biol. 252:263-273, 1995.
11. Duncan, B.S., Olson, A.J. Approximation and characterization of molecular surfaces. Biopolymers 33:219-229, 1993.
12. Duncan, B.S., Olson, A.J. Shape analysis of molecular surfaces. Biopolymers 33:231-238, 1993.
13. Lijnzaad, P., Berendsen, H.J.C., Argos, P. A method for detecting hydrophobic patches protein. Proteins 26:192-203, 1996.
14. Young, L., Jernigan, R.L., Covell, D.G. A role for surface hydrophobicity in protein-protein recognition. Prot. Sci. 3:717-729, 1994.
15. Meyer, M., Wilson, P., Schomburg, D. Hydrogen bonding and molecular surface shape complementarity as a basis for protein docking. J. Mol. Biol. 264:199-210, 1996.
16. Nicholls, A. "GRASP: Graphical Representation and Analysis of Surface Properties." New York: Columbia University Press, 1992.
17. Boobbyer, D.N.A., Goodford, P.J., McWhinnie, P.M., Wade, R.C. New hydrogen-bond potentials for use in determining energetically favourable binding sites on molecules of known structure. J. Med. Chem. 32:1083-1094, 1989.
18. Goodford, P.J. A computational procedure for determining energetically favourable binding sites on biologically important macromolecules. J. Med. Chem. 28:849-857, 1985.
19. Wade, R.C., Clark, K.J., Goodford, P.J. Further development of hydrogen bond functions for use in determining energetically favourable binding sites on molecules of known structure. I. Ligand probe groups with the ability to form two hydrogen bonds. J. Med. Chem. 36:140-147, 1993.
20. Miranker, A., Karplus, M. Functionality maps of binding sites: A multiple copy simultaneous search method. Proteins 11:29-34, 1991.
21. Miranker, A., Karplus, M. An automated method for dynamic ligand design. Proteins 23:472-490, 1995.
22. Ruppert, J., Welch, W., Jain, A. Automatic identification and representation of protein binding sites for molecular docking. Prot. Sci. 6:524-533, 1997.
23. Bohacek, R.S., McMartin, C. Definition and display of steric, hydrophobic, and hydrogen-bonding properties of ligand binding sites in proteins using Lee and Richards accessible surface: Validation of a high-resolution graphical tool for drug design. J. Medicinal Chem. 35:1671-1684, 1992.
24. Lee, B., Richards, F.M. The interpretation of protein structures: Estimation of static accessibility. J. Mol. Biol. 55:379-400, 1971.
25. Laskowski, R.A., Thornton, J.M., Humblet, C., Singh, J. X-SITE: use of empirically derived atomic packing preferences to identify favourable interaction regions in the binding sites of proteins. J. Mol. Biol. 259:175-201, 1996.
26. Kuntz, I.D., Blaney, J.M., Oatley, S.J., Langridge, R., Ferrin, T.E. A geometric approach to macromolecule-ligand interactions. J. Mol. Biol. 161:269-288, 1982.
27. DesJarlais, R.L., Dixon, J.S. A shape-and chemistry-based docking method and its use in the design of HIV-1 protease inhibitors. J. Comp.-Aided Design 8:231-242, 1994.
28. Shoichet, B.K., Kuntz, I.D. Matching chemistry and shape in molecular docking. Prot. Eng. 6:723-732, 1993.
29. Martin, Y.C., Danaher, E.B., May, C.S., Weninger, D., Van Drie, J.H. In "QSAR: Quantitative Structure-Activity-Relationships in Drug Design." New York: Alan Liss, 1989, pp. 177-181.
30. Cannon, J.G. In "Burger's Medicinal Chemistry and Drug Discovery," 5th ed., Vol. 1. Wolff, M.E., (ed). New York: Wiley & Sons, 1995, pp. 783-802.
31. Pang, Y.P., Kollman, P.A. Applications of free energy derivatives to analog design. Perspectives in Drug Discovery and Design 3:106-122, 1995.
32. Bohacek, R.S., McMartin, C., Guida, W.C. The art and practice of structure-based drug design - a molecular modeling perspective. Medicinal Res. Rev. 16:3-50, 1996.
33. Reich, S.H., Melnick, M., Davies, J.F.N., et al. Protein structure-based design of potent orally bioavailable, non-peptide inhibitors of human immunodeficiency virus protease. Proceedings of the National Academy of Sciences of the United States of America 92:3298-3302, 1995.
34. Blumenthal, L.M. "Theory and Applications of Distance Geometry." New York: Chelsea, 1970.
35. Crippen, G.M., Havel, T.F. "Distance Geometry and Molecular Conformation." New York: Wiley Research Studies Press, 1988.
36. Baker, E.N., Hubbard, R.E., Hydrogen bonding in globular proteins. Prog. Biophys. Mol. Biol. 44:97-179, 1984.
37. Meng, E.C., Schoichet, B.K., Kuntz, I.D. Automated docking with grid-based energy evaluation. J. Comp. Chem. 13:505-524, 1992.
38. Shoichet, B.K., Bodian, D.L., Kuntz, I.D. Molecular docking using shape descriptors. J. Comput. Chem. 13:380-397, 1992.
39. Bernstein, F.C., Koetzle, T.F., Williams, G.J.B., Meyer, E.T.J., Brice, M.D., Rodgers, J.R., Kennard, O., Shimanouchi, T., Tasumi, M. The protein data bank: A computer-based archival file for macromolecular structures. J. Mol. Biol. 112:535-542, 1977.
40. Somoza, J. Dept. Biophys. & Biochem., UCSF.
41. Davies, J.F., Delcamp, T.J., Prendergast, N.J., Ashford, V.A., Fresheim, J.H., Kraut, J. Crystal structures of recombina'nt human dihydrofolate reductase complexed with folate and 5-deazofolate. Biochemistry 29:9467-9479, 1990.
42. Gschwend, D.A., Good, A.C., Kuntz, I.D. Molecular docking towards drug discovery. J. Mol. Recog. 8:175-186, 1996.
43. Kraut, J., Mathews, D.A. In: "Biological Macromolecules," Vol. 3. Jurnak, F.A., McPherson, A. (eds). New York: Wiley & Sons, 1987, pp 1-72.
44. Erickson, J., Neidhart, D.J., van Drie, J., et al. Design, activity and 2.8 Å crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease. Science 249:527-533, 1990.
45. Holloway, M.K., Wai, J.M., Halgren, T.A., et al. A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site. J. Med. Chem. 38:305-317, 1995.
46. Rutenber, E., Fauman, E.B., Keenan, R.J., et al. Structure of a non-peptide inhibitor complexed with HIV-1 protease. J. Biol. Chem. 268:15343-15346, 1993.
47. Wlodawer, A., Erickson, J.W. Structure-based inhibitors of HIV-1 protease. Ann. Rev. Biochem. 62:543-585, 1993.
48. Yamazaki, T., Hinck, A.P., Wang, Y.-X., et al. Three-dimensional solution structure of the HIV-1 protease complexed with DMP323, a novel cyclic urea-type inhibitor, determined by nuclear magnetic resonance spectroscopy. Prot. Sci. 5:495-506, 1996.
49. Holt, D.A., Luengo, J.I., Yamashita, D.S., et al. Design, synthesis, and kinetic evaluation of high-affinity Fkbp ligands and the X-ray crystal structures of their complexes with Fkbp12. J. Am. Chem. Soc. 115:9925-9938, 1993.
50. Brandstetter, H., Turk, D., Hoeffken, H.W., et al. Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA: A starting point for improving antithrombotics. J. Mol. Biol. 226:1085-1099, 1992.
51. Grootenhuis, P.D.J., van Galen, P.J.M. Correlation of binding affinities with non-bonded interaction energies of thrombin-inhibitor complexes. Acta Cryst. Sect. D 51:560-566, 1995.
52. Reich, S.H., Fuhry, M.A.M., Nguyen, D., et al. Design and synthesis of novel 6,7-imidazotetrahydroquinoline inhibitors of thymidylate synthase using iterative protein crystal structure analysis. J. Med. Chem. 35:847-858, 1992.
53. Varney, M.D., Marzoni, G.P., Palmer, C.L., et al. Crystal structure-based design and synthesis of benz[cd]indole containing inhibitors of thymidylate synthase. J. Med. Chem. 35:663-676, 1992.
54. Shoichet, B.K., Stroud, R.M., Santi, D.V., Kuntz, I.D., Perry, K.M. Structure-based discovery of inhibitors of thymidylate synthase. Science 259:1445-1450, 1993.
55. Somoza, J.R., Chin, M.S., Focia, P.J., Wang, C.C., Fletterick, R.J. Crystal structure of the hypoxanthine guaninexanthine phosphoribosyltransferase from the protozoan parasite tritrichomonas foetus. Biochemistry 35:7032-7040, 1996.
56. Wells, J.A., de Vos, A.M. Hematopoietic receptor complexes. Ann. Rev. Biochem. 65:609-634, 1996.
57. Wells, J.A. Binding in the growth hormone receptor complex. Proceedings Nat. Acad. Sci. USA 93:1-6, 1996.
58. Ewing, T., Kuntz, I. Critical evaluation of search algorithms for automated molecular docking and database screening. J. Comp. Chem. 18:1175-1189.
59. Weiner, S.J., Kollman, P.A., Case, D.A., et al. A new force field for molecular mechanics simulation of nucleic acids and proteins. J. Am. Chem. Soc. 106:765-784, 1984.
60. Weiner, S.J., Kollman, P.A., Hguyen, D.T., Case, D.A., An all atom force field for simulations of proteins and nucleic acids. J. Comp. Chem. 7:230-252, 1986.
61. Oefner, C., Winkler, F., D'Arcy, A. Structure determination of P. carinii dihydrofolate reductase by X-ray crystallography, unpublished results.
62. Silva, A. NIH, Bethesda, MD.
63. Goodsell, D.S., Olson, A.J. Automated docking of substrates to proteins by simulated annealing. Proteins 8:195-202, 1990.
64. Goodsell, D.S., Lauble, H., Stout, C.D., Olson, A.J. Automated docking in crystallography - Analysis of the substrates of aconitase. Proteins 17:1-10, 1993.
65. Eisen, M.B., Wiley, D.C., Karplus, M., Hubbard, R.E. HOOK: A program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site. Proteins 19:199-221, 1994.
66. Cohen, N.C., Blaney, J.M., Humblet, C., Gund, P., Barry, D.C. Molecular modeling software and methods for medicinal chemistry. J. Med. Chem. 33:883-894, 1990.
67. Danziger, D.J., Dean, P.M. Automated site-directed drug design: A general algorithm for knowledge acquisition about hydrogen-bonding regions at protein surfaces. Proc. R. Soc. Lond. B 236:101-113, 1989.
68. Danziger, D.J., Dean, P.M. Automated site-directed drug design: The prediction and observation of ligand point positions at hydrogen-bonding regions on protein surfaces. Proc. R. Soc. Lond. B 236:115-124, 1989.
69. Masek, B.B., Merchant, A., Matthew, J.B. Molecular skins - A new concept for quantitative shape matching of a protein with its small molecule mimics. Proteins 17:193-202, 1993.
70. Jorgensen, W.L. Rusting of the lock and key model for protein-ligand binding. Science 254:954-955, 1991.
71. Koshland, D.E. Application of a theory of enzyme specificity to protein synthesis. Proceed. Natl. Acad. Sci. USA 44:98-104, 1958.
72. Leach, A.R. Ligand docking to proteins with discrete side-chain flexibility. J. Mol. Biol. 235:345-356, 1994.
73. Knegtel, R., Oshiro, C., Kuntz, I. Molecular docking to ensembles of protein structures. J. Mol. Biol. 266:424-440, 1996.
74. Gerstein, M., Lesk, A.M., Chothia, C. Structural mechanisms for domain movements in proteins. Biochemistry 33:6739-6749, 1994.
75. Lewis, R.A., Roe, D.C., Huang, C., Ferrin, T.E., Langridge, R., Kuntz, I.D. Automated site-directed drug design using molecular lattices. J. Mol. Graphics 10:66-78, 1992.
76. Roe, D.C., Kuntz, I.D. BUILDER v. 2: Improving the chemistry of a de novo design strategy. J. Comput. Aided Mol. Design 9:269-282, 1995.
77. Bohacek, R.S., McMartin, C. Multiple highly diverse structures complementary to enzyme binding sites: Results of extensive application of a de novo design method incorporating combinatorial growth. J. Am. Chem. Soc. 116:5560-5571, 1994.
78. McDonald, I.K., Thornton, J.M. "Atlas of Side-Chain and Main-Chain Hydrogen Bonding," WWW. ed. http://www. biochem.ucl.ac.uk/∼mcdonald/atlas/index.html:, 1994.
79. Meng, E.C., Ph.D., University of California, San Francisco, 1993.